Tag: Companion Diagnostic Tests

Home / Companion Diagnostic Tests

Categories

Zolbetuximab-clzb with chemotherapy is approved by the USFDA for gastric or gastroesophageal junction adenocarcinoma

 On October 18, 2024, the Food and Drug Administration sanctioned zolbetuximab-clzb (Vyloy, Astellas Pharma US, Inc.), a claudin 18.2 (CLDN18.2)-targeted cytolytic antibody, in conjunction with fluor...
companion-diagnostic-tests

We Are Online! Chat With Us!
Scan the code